Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Targeted stem-cell attack could make transplants safer

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 576, 18-19 (2019)

doi: https://doi.org/10.1038/d41586-019-03601-5

Updates & Corrections

  • Correction 03 December 2019: An earlier version of the story incorrectly said that Judith Shizuru’s team collaborated with Forty Seven for the clinical trial of the c-Kit antibody mentioned; Forty Seven was not part of this collaboration.

References

  1. Snarski, E. et al. Bone Marrow Transpl. 51, 398-402 (2016).

    Article  Google Scholar 

  2. Sullivan, K. M. et al. N. Engl. J. Med. 378, 35-47 (2018).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links